Key Sleep Supplements Market Players:
- Nature Made
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bayer AG
- By-Health
- NOW Foods
- Takeda Pharmaceuticals
- Blackmores
- Himalaya Wellness
- Nutrafol
- Pure Encapsulations
- PharmaNord
- Zarbee’s Naturals
- H&H Group (Swisse)
- Solaray
- Life Extension
- Amway (Nutrilite)
- VMS BioMedix
- Kyolic (Wakunaga)
- Dr. Willmar Schwabe
- GN Laboratories
- Organic India
The highly fragmented sleep supplements market is experiencing and possession of more than 40%, marked by the top five key global players. The strategic initiatives incorporated by the business to derive a competitive edge include acquisition, regulatory alignment, and implementation of the business model of direct-to-consumer. Nestlé acquired Pure Encapsulation in 2022 to expand their business performance in the concerned market, which positively impacted business growth. Takeda from Japan, on the other hand, gained clearance for the first senior-targeted melatonin that upsurged their sales value in 2023. More than 28% of the U.S. sales of NOW Foods are derived through DTC expansion utilizing the Amazon storefront.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of sleep supplements is assessed at 8.8 billion.
Sleep Supplements Market size was valued at USD 8.8 billion in 2025 and is expected to reach USD 13 billion by 2035, expanding at around 6% CAGR during the forecast period i.e., between 2025-2037.
North America industry is expected to dominate majority 40% revenue share by 2035, owing to increasing awareness about sleeping disorders, rise in change in lifestyle, and rise in research for the development of various sleeping aids.
The major players in the market are Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, CareFusion Corporation, Tempur-Pedic Management Inc., Serta International, Compumedics Limited, Natus Medical Incorporated, GlaxoSmithKline plc. and , among others.
